📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression. (2018)

First Author: Roseman L

Attributed to: Psilocybin as a treatment for major depression funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.neuropharm.2017.12.041

PubMed Identifier: 29288686

Publication URI: http://europepmc.org/abstract/MED/29288686

Type: Journal Article/Review

Volume: 142

Parent Publication: Neuropharmacology

ISSN: 0028-3908